Actively Recruiting
Trauma-Focused Cognitive Behavioral Therapy in Unaccompanied Refugee Minors With PTSD in Greece: An RCT
Led by Theodora Anastasiou · Updated on 2025-05-16
60
Participants Needed
1
Research Sites
146 weeks
Total Duration
On this page
Sponsors
T
Theodora Anastasiou
Lead Sponsor
G
Greek Ministry of Migration and Asylum
Collaborating Sponsor
AI-Summary
What this Trial Is About
This single-blinded, multicentered, randomized controlled trial aims to evaluate the effectiveness of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) compared to Treatment-as-Usual (TAU) in reducing post-traumatic stress symptoms among unaccompanied refugee minors (UAMs) residing in accommodation centers and Supported Independent Living (SIL) programs in Greece. Participants aged 15-18 will be randomly assigned to either a TF-CBT intervention group or a TAU control group. The intervention will be delivered by trained psychologists under supervision and culturally adapted to the Greek refugee context. Assessments will occur at baseline, post-intervention, and three months later, using standardized psychometric tools. Secondary outcomes include changes in comorbid psychiatric symptoms (depression, anxiety, somatic symptoms), emotional and behavioral difficulties, and quality of life. The study also investigates potential moderators of treatment response such as age, gender, trauma history, and psychiatric comorbidity.
CONDITIONS
Official Title
Trauma-Focused Cognitive Behavioral Therapy in Unaccompanied Refugee Minors With PTSD in Greece: An RCT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be unaccompanied upon arrival in Greece and aged between 15-18 years old.
- Diagnosed with PTSD based on DSM-5 criteria or have moderate to high trauma-related distress on the Child and Adolescent Trauma Screen (CATS).
- Reside in an accommodation center or Supported Independent Living program for unaccompanied minors in Greece.
- Have had a stable living arrangement for at least 2-3 weeks prior to the intervention.
- Not expected to relocate within 2-3 months following the start of the intervention.
You will not qualify if you...
- Diagnosed intellectual disability (IQ < 70) or other developmental disorder.
- Acute suicidality or life-threatening self-harm behavior.
- Significant risk of harm to others.
- Comorbidity with bipolar disorder or a psychotic disorder.
- Current substance abuse.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
General Secretariat for Vulnerable Persons and Institutional Protection, Ministry of Migration and Asylum
Athens, Greece, 182 33
Actively Recruiting
Research Team
T
Theodora Anastasiou, PhD candidate
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here